CLINICAL SUPPLY MANAGEMENT ARTICLES
Why Clinical Supply Problems Rarely Start In Clinical Supply
Clinical supply failures often start long before a stockout, when CMC, quality, regulatory, and clinical decisions create risks that supply teams inherit too late.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Randomization & trial supply management (RTSM) are critical functions of clinical trial IRT systems, supporting patient randomization plus managing drug inventory, site resupply, and participant dispensation.
-
Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
-
Explore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
Shipping and storing advanced therapeutics are complex processes, but advancements in accountability, wearables, and technology capture real-time factors critical to safety and protocol.
-
This white paper addresses the common challenges faced by biopharma organizations with regards to supply chain management and offers insight into solutions by leveraging the RTSM/IRT.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.